Rigel Pharmaceuticals (RIGL) Operating Leases (2019 - 2026)
Rigel Pharmaceuticals (RIGL) posted quarterly Operating Leases of $228000.0 for Q1 2026, down 73.61% year-over-year from $864000.0 in Q1 2025, and down 42.28% quarter-over-quarter from $395000.0 in Q4 2025.
Rigel Pharmaceuticals (RIGL) Operating Leases (2019 - 2026) Analysis & Trends
Rigel Pharmaceuticals' Operating Leases history runs 8 years deep, the most recent figure standing at $228000.0 for Q1 2026.
- In Q1 2026, Operating Leases fell 73.61% year-over-year to $228000.0; the TTM figure through Mar 2026 stood at $228000.0 (down 73.61% YoY), while the FY2025 annual figure was $395000.0, changed N/A from the prior year.
- Operating Leases for Q1 2026 stood at $228000.0, down from $395000.0 in the prior quarter.
- The five-year high for Operating Leases was $8.3 million in Q1 2022, with the low at $100000.0 in Q1 2024.
- The 5-year median for Operating Leases is $592000.0 (2023), against an average of $1.2 million.
- The sharpest annual moves came in 2023 and 2025: Operating Leases slumped 90.34% in 2023, then soared 764.0% in 2025.
- Rigel Pharmaceuticals' Operating Leases stood at $972000.0 in 2022, then slumped by 70.68% to $285000.0 in 2023, then plunged by 64.91% to $100000.0 in 2024, then jumped by 295.0% to $395000.0 in 2025, then slumped by 42.28% to $228000.0 in 2026.
- Business Quant data shows RIGL's Operating Leases at $228000.0 in Q1 2026, $395000.0 in Q4 2025, and $556000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Rigel Pharmaceuticals | 795.39 Mn | 700.06 Mn | 70.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 58,000.00 |
| Mar 31, 2026 | 228,000.00 |
| Dec 31, 2025 | 395,000.00 |
| Sep 30, 2025 | 556,000.00 |
| Jun 30, 2025 | 714,000.00 |
| Mar 31, 2025 | 864,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | 285,000.00 |
| Sep 30, 2023 | 466,000.00 |
| Jun 30, 2023 | 628,000.00 |
| Mar 31, 2023 | 802,000.00 |
| Dec 31, 2022 | 972,000.00 |
| Mar 31, 2022 | 8.30 Mn |
| Dec 31, 2021 | 759,000.00 |
| Sep 30, 2021 | 3.31 Mn |
| Jun 30, 2021 | 15.10 Mn |
| Mar 31, 2021 | 8.30 Mn |
| Dec 31, 2020 | 19.30 Mn |
| Sep 30, 2020 | 12.93 Mn |
| Jun 30, 2020 | 15.25 Mn |